Telcon RF Pharmaceutical Inc. (200230)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
2,395. 00
+50
+2.1322%
₩
47.78B Market Cap
- P/E Ratio
- Div Yield
38,199 Volume
- Eps
₩ 2,345
Previous Close Want to track 200230 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
200230 closed today higher at ₩2,395, an increase of 2.1322% from yesterday's close, completing a monthly decrease of -0.4158% or -₩10. Over the past 12 months, 200230 stock gained 161.1778%.
200230 is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Telcon RF Pharmaceutical Inc. has completed 6 stock splits, with the recent split occurring on Aug 22, 2025.
The company's stock is traded on one exchange.
Telcon RF Pharmaceutical Inc. (200230) FAQ
What is the stock price today?
The current price is ₩2,395.00.
On which exchange is it traded?
Telcon RF Pharmaceutical Inc. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 200230.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 47.78B.
Has Telcon RF Pharmaceutical Inc. ever had a stock split?
Telcon RF Pharmaceutical Inc. had 6 splits and the recent split was on Aug 22, 2025.
Telcon RF Pharmaceutical Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | KRX SM Exchange | KR7200230001 ISIN |
| South Korea Country | 126 Employees | - Last Dividend | 4 Jul 2025 Last Split | - IPO Date |
Overview
TELCON RF PHARMACEUTICAL. Inc., initially founded as Telcon Co., Ltd. in 1999, has established itself as a leading entity in the global market, renowned for its sophisticated development, production, and sales of RF coaxial connectors. With its headquarters located in Yongin-si, South Korea, the company has expanded its product portfolio to include not only telecommunications components but also pharmaceuticals. This diversification underscores TELCON RF PHARMACEUTICAL. Inc.'s commitment to innovation and its ambition to cater to a broader market. Over the years, it has not only solidified its presence worldwide but also redefined its identity to better reflect its expanded range of offerings.
Products and Services
- RF Coaxial Connectors - These connectors are crucial in telecommunications and data communication applications, ensuring high-quality signal transmission with minimal loss. TELCON RF PHARMACEUTICAL. Inc. takes pride in offering a wide range of connectors designed to meet various technical and environmental requirements.
- Coaxial Couplers, Distributors, and Arresters - The company’s portfolio extends to include coaxial couplers, distributors, and arresters, which play significant roles in the management and distribution of RF signals. These products are engineered to integrate seamlessly into sophisticated telecommunications infrastructure, providing solutions that enhance signal quality and system reliability.
- Cable Assemblies - TELCON RF PHARMACEUTICAL. Inc. also specializes in the production of high-quality cable assemblies, customized to support the unique needs of their clients. Ranging from simple to complex designs, these assemblies are pivotal for a myriad of applications across telecommunications, medical devices, and other critical industries.
- Pharmaceuticals - Marking a significant diversification in its business model, the company has ventured into the pharmaceutical sector. Leveraging its expertise in research and development, TELCON RF PHARMACEUTICAL. Inc. aims to contribute to the healthcare industry by providing innovative pharmaceutical solutions intended to improve patient outcomes.
Contact Information
Address: 54, Gongse-ro
Phone: 82 3 1371 8500
Website: https://www.telcon.co.kr
